Maruti Suzuki rating – Buy- Robust performance in Q4FY22
时间:2024-06-26 13:28:58 阅读(143)
MSIL reported a strong beat in Q4FY22, led by stable commodity prices and lower discounts. Favourable product lifecycle will drive volumes, market share, and margin, whereas the JPY depreciation will dilute the impact of commodity prices in H1FY23. We raise our FY23e/FY24e EPS by 7%/3%, factoring in a ramp-up in exports and forex changes. We maintain our Buy rating, with a target price of Rs 10,000/share (~27x Jun’24E consolidated EPS).
Lower discounts and stable commodity cost boost marginRevenue/Ebitda/PAT grew 11%/22% /58% y-o-y to ~Rs 267.4/24.3/18.4 bn. Revenue/Ebitda grew 25.5%/ 7% y-o-y to Rs 883/57 bn, while adjusted PAT fell 11% to Rs 37.7 bn in FY22. Net realisations grew 12% y-o-y (+1.4% q-o-q) to Rs 547.2k (est. Rs 550.5k) due to price hikes and lower discounts at Rs 11.1k/unit (v/s Rs 15.2k q-o-q and Rs 16.6k/unit in Q4FY21). This, coupled with stable commodity cost, boosted gross margin by 180bp q-o-q (+40bp y-o-y) to 26.5% (est. 24%).
Highlights from management commentaryGood demand, coupled with recent product launches (Baleno, Celerio, and XL6), has further increased its order book to 320k at present (v/s 268k as of Mar’22 v/s 240k as of Dec’21), of which CNG constitutes 40%. Semiconductor shortage resulted in a production loss of 270k (mainly in the domestic market). The management said the situation is unpredictable and may impact slightly in FY23. Cost inflation had no impact or benefit in Q4FY22. It expects an increase in Q1/H1FY23, though it is difficult to quantify, as negotiations on steel prices are ongoing.
Valuation and viewStrong demand and favourable product lifecycle for MSIL augurs well for market share and margin. We expect a recovery in market share and margin in H2FY23, led by an improvement in supplies, favourable product lifecycle, mix, price action/cost-cutting, and operating leverage. The stock trades at 33.7x/21.8x FY23E/FY24E consolidated EPS. We maintain our Buy rating, with a TP of `10,000/share (27x Jun’24E consolidated EPS).
上一篇:BharatNet- Tejas, TCS seek fair shot
下一篇:Year of concerts- From Taylor Swift’s Eras Tour To Madonna’s Celebration Tour
猜你喜欢
- Benchmark indices inch closer to key support levels, extent of upside uncertain
- Market valuation of 6 of top-10 most valued firms jumps Rs 2 lakh cr; Reliance, TCS big winners
- Bharat Bond ETFs cross Rs 50,000 crore AUM mark
- Quarterly earnings, crude prices, geopolitical uncertainties to dictate market trends this week- Analysts
- Blackstone’s Nexus Select Trust REIT Rs 3,200 cr IPO to open 9 May; combination of fresh issue, OFS
- Mankind Pharma IPO’s success raises revival hopes for moribund public issue market
- Punjab & Sind Bank, RVNL, India Pesticides, Hariom Pipe Industries, MOIL, Kwality Pharma stocks in focus
- Rating- buy; Dr Reddy’s and Mayne deal is a valuable investment
- Budget 2024- Boost healthcare spending, reform iGST and address embedded tax issues, industry leaders urge